VIM and lung adenocarcinoma: This study showed that treatment of A549 lung adenocarcinoma cells with a specific PRMT5 inhibitor, GSK591, suppressed the expression of TGF-β1-induced EMT protein markers such as Snail and Vimentin, treatment of T1-44 alone did not suppress the expression of PRMT5.